Self-prescribed TRT mistakes: what the science actually says
Quick answer
The creator describes self-administered testosterone at 250mg, which exceeds standard therapeutic TRT dosing (typically 100-200mg weekly per Endocrine Society guidelines) and enters performance-enhancement territory. He dismisses transdermal gels without clinical basis, which could discourage patients from a legitimate, guideline-supported delivery method. No mention of bloodwork, hematocrit monitoring, or physician involvement appears anywhere in the video.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @alphaclubsupps actually say?
The creator ran through three things he says he got wrong when he started self-prescribing testosterone: using a 23-gauge needle in the quad, running 250mg as a dose he thought was sustainable, and using testosterone gel because he wanted to avoid injections. He calls the gel "double shit" and frames all three as lessons for beginners.
A few things to flag immediately. This person is openly describing self-prescribing testosterone, which in most countries requires a prescription. He offers no bloodwork, no physician oversight, and no safety net. His framing as cautionary humor does not change the fact that he is coaching an audience on unmonitored hormone use. That context matters for everything that follows.
Does the science back this up?
Partially, but not cleanly. The needle gauge and injection site point has real clinical support, the dose claim is roughly accurate, and the gel critique is where things get genuinely complicated.
On needle gauge: 23G is on the thicker end for subcutaneous or shallow intramuscular injections, and the quad is considered a less forgiving site compared to the ventrogluteal or dorsogluteal areas for most patients. A 2021 review in the Journal of Clinical Endocrinology and Metabolism noted that ventrogluteal injections are associated with fewer complications and less pain than vastus lateralis sites in many patients (Kovac et al., 2021). That checks out.
On 250mg: Clinical TRT doses typically range from 75mg to 200mg of testosterone cypionate or enanthate per week, depending on the patient. The Endocrine Society guidelines place most therapeutic doses between 100mg and 200mg weekly. Running 250mg is not a standard therapeutic dose. It is closer to what you see in performance-enhancing contexts. He is right that it is high.
On gel being inferior: this is where the creator oversimplifies badly. Gels are a legitimate, FDA-approved delivery method for hypogonadism. They are not categorically worse.
What did they get wrong (or right)?
He got the dose point mostly right, and the needle site point has legitimate clinical grounding. But calling testosterone gel "double shit" is just wrong, and dangerously reductive for a public audience.
Transdermal testosterone gels achieve stable serum testosterone levels and avoid the peak-and-trough pattern associated with weekly injections. A 2019 randomized trial in Andrology (Ramasamy et al., 2019) found that daily gel application produced more stable testosterone levels compared to weekly intramuscular injections in some patients. Gels are also the preferred route for patients with needle phobia, bleeding disorders, or those who struggle with injection technique. The idea that gels are inferior across the board is not supported by the literature.
What gels do have is a real transfer risk to partners and children if applied incorrectly, and adherence issues because daily application is easy to skip. Those are legitimate clinical concerns. "Double shit" is not a clinical concern, it is an opinion dressed up as a fact.
What should you actually know?
Self-prescribing testosterone is not a gray area. It carries real risks that do not disappear just because someone learned from their own trial and error.
Unmonitored testosterone use can suppress natural hormone production, raise hematocrit to dangerous levels, affect fertility, and cause cardiovascular changes. A 2023 meta-analysis in JAMA Network Open (Sharma et al., 2023) confirmed associations between supraphysiologic testosterone use and adverse cardiovascular outcomes, including increased erythrocytosis and changes in lipid profiles. These are not hypothetical risks.
If you have symptoms of hypogonadism, which include low energy, reduced libido, depression, and poor recovery, the right move is a blood panel and a physician consultation, not a TikTok comment section. Platforms like FormBlends exist specifically to provide that oversight. The difference between TRT that helps and TRT that harms is often monitoring, not dosing intuition.
Injection site and gauge selection matters, but it should be guided by a clinician who knows your anatomy and experience level, not reverse-engineered from someone else's painful mistakes on social media.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Self-prescribed TRT mistakes: what the science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Self-prescribed TRT mistakes: what the science actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator describes self-administered testosterone at 250mg, which exceeds standard therapeutic TRT dosing (typically 100-200mg weekly per Endocrine Society guidelines) and enters performance-enhancement territory.
FormBlends verdict
The creator describes self-administered testosterone at 250mg, which exceeds standard therapeutic TRT dosing (typically 100-200mg weekly per Endocrine Society guidelines) and enters performance-enhancement territory. He dismisses transdermal gels without clinical basis, which could discourage patients from a legitimate, guideline-supported delivery method. No mention of bloodwork, hematocrit monitoring, or physician involvement appears anywhere in the video.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes self-administered testosterone at 250mg, which exceeds standard therapeutic TRT dosing (typically 100-200mg weekly per Endocrine Society guidelines) and enters performance-enhancement territory. He dismisses transdermal gels without clinical basis, which could discourage patients from a legitimate, guideline-supported delivery method. No mention of bloodwork, hematocrit monitoring, or physician involvement appears anywhere in the video.
- Standard therapeutic TRT doses range from 100mg to 200mg of testosterone cypionate weekly per Endocrine Society guidelines. 250mg exceeds this range and is closer to performance-enhancing use.
- Testosterone gel is FDA-approved and clinically legitimate. A 2019 Andrology trial (Ramasamy et al.) found it produced more stable testosterone levels than weekly injections in some patients.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Standard therapeutic TRT doses range from 100mg to 200mg of testosterone cypionate weekly per Endocrine Society guidelines. 250mg exceeds this range and is closer to performance-enhancing use.
- Testosterone gel is FDA-approved and clinically legitimate. A 2019 Andrology trial (Ramasamy et al.) found it produced more stable testosterone levels than weekly injections in some patients.
- Ventrogluteal injection sites are generally associated with fewer complications than the vastus lateralis (quad) for intramuscular testosterone, per Kovac et al. (2021, Journal of Clinical Endocrinology and Metabolism).
- Unmonitored testosterone use can raise hematocrit to dangerous levels. The American Urological Association recommends stopping or reducing dose if hematocrit exceeds 54%.
- A 2023 JAMA Network Open meta-analysis (Sharma et al.) linked supraphysiologic testosterone use to adverse cardiovascular outcomes, including changes in lipid profiles and erythrocytosis.
- Self-prescribing testosterone is not legal without a prescription in the US, UK, Canada, and Australia. Physician oversight is not optional, it is the mechanism that separates therapeutic use from harm.
- Needle gauge and injection site selection should be guided by a clinician based on individual anatomy and experience, not reverse-engineered from social media accounts.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Alpha Club Supplements UK · TikTok creator
5.1K views on this video
💥 The 3 biggest mistakes I made when I first started self-prescribing TRT 💥 If you are just getting started, please learn from my stupidity 😂 ❌ 23G needle into the quads Hurt like hell, awful recovery, terrible spot for most guys ❌ Running 250mg thinking it was a normal dose That is basically a borderline cycle for most men I ran out of road fast with side effects and no place to go ❌ Testogel Absorption all over the place, daily swings, messy, expensive, and never stable Horrendous exper
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Alpha Club Supplements UK, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.